Sarepta therapeutics to announce first quarter 2025 financial results

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, will report first quarter 2025 financial results after the nasdaq global market closes on tuesday, may 6, 2025. subsequently, at 4:30 p.m. e.t., the company will host a conference call to discuss its first quarter 2025 financial results. the event will be webcast live under the investor relations section of sarepta's website at https://investorrelations.sarept.
SRPT Ratings Summary
SRPT Quant Ranking